New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

Ozempic, a Type 2 diabetes medication that has gained widespread attention, is known for its appetite-suppressing properties.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...